Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

Recruiting Observational Study
Alpha-1 Antitrypsin Deficiency AAT Deficiency AATD Cystic Fibrosis (CF)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
220 (estimated)
Sponsor
University of Florida · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to look at how Alpha-1-antitrypsin (AAT) deficiency and Cystic Fibrosis (CF) affect white blood cells in the lungs, called macrophages, and their ability to work.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Signed informed consent * Male or female 18 years of age or older * Negative pregnancy test for women of childbearing potential * Hemoglobin \>12.5 g/dl measured on the day of participation * Negative urine nicotine test Exclusion Criteria: * Pregnancy or breastfeeding * Wei…
Contacts

Allison E. Faunce, B.A.

352-273-8666

Allison.Faunce@medicine.ufl.edu

CONTACT

Michelle Owens, RN, BSN

352-273-6339

Sandra.Owens@medicine.ufl.edu

CONTACT